BASF: Between Oversold Extremes and a Cost-Cutting Marathon
11.06.2026 - 17:45:15 | boerse-global.de
The chemical giant BASF is sending mixed signals to the market. A modest bounce in the share price this week—up 2.68% to €49.10—masks the deeper structural overhaul underway. Investors are being asked to back a multi-year restructuring plan while the stock trades at levels that, by some measures, look technically distressed.
That distress was acute just days earlier, when the shares touched €47.82 and the relative strength index (RSI) plunged to 29.7—deep in oversold territory. The 50-day moving average of €52.28 lay well out of reach, and the stock had shed roughly 10% in 30 days. Friday’s recovery has lifted the RSI only to 39.6, still below the 40 mark that signals persistent weakness.
The centrepiece of the turnaround is Project CoreShift, a programme targeting a 20% reduction in cash-effective fixed costs by 2029. The cuts will span business lines generating roughly €40 billion in revenue. Management has pencilled in an operating result of up to €7 billion for 2026 and a free cash flow cap of €2.3 billion. Between 2025 and 2028, at least €12 billion is earmarked for shareholder returns.
A key prop for the stock is about to disappear. The current share buyback programme, under which BASF has repurchased around 27.8 million of its own shares, will end in June. From then on, the operational business will have to support the price without that artificial floor. The stock remains more than 10% below its 52-week high of €55.05 and has lost ground against both the 50-day (€52.21) and 100-day (€50.11) moving averages.
Should investors sell immediately? Or is it worth buying BASF?
Operationally, the picture is mixed. CEO Markus Kamieth reported a strong May following a robust April, and pricing across many chemical products has held steady. But the demand spike triggered by uncertainties around the Iran conflict is already fading. More significantly, the company itself has acknowledged that earlier assumptions about global growth and industrial production may have been too optimistic. The combination of currency headwinds, softer prices, and geopolitical strains continues to weigh.
China remains the most important volume driver, yet it is a double-edged sword. The massive Zhanjiang Verbund site, which opened in March 2026 at a cost of €8.7 billion—comfortably under budget—represents a considerable operational achievement. New aroma-ingredient capacities have also come online both there and in Ludwigshafen. But global overcapacity in petrochemicals is undermining margins, and Kamieth has deliberately dampened earnings expectations for the new plant. The message is clear: BASF is prioritising profitability over sheer scale, even if that means conceding volume leadership to competitors.
The real test of credibility, however, lies in Ludwigshafen. The site agreement for 2026 to 2028 is supposed to anchor the location’s role in the group’s long-term success. If Europe’s largest chemical complex can consistently contribute to earnings, the market’s perception of the stock could improve markedly. If it remains a symbol of high fixed costs and energy disadvantage, every cyclical headwind will hammer the share price.
BASF at a turning point? This analysis reveals what investors need to know now.
Technically, the stock is not broken. It is trading just above its 200-day moving average of €46.89, and the deeply oversold RSI reading could fuel a short-term counter-move. But such a move will need operational confirmation to last. Year-to-date, the shares are still up roughly 7%, and the 12-month gain stands above 11%—hardly a picture of complete capitulation.
For now, BASF remains a patience trade, not a momentum one. The cost cuts, the volume story in China, and the shareholder returns promise all point in the right direction. But until the company can prove that these elements are delivering sustainable earnings improvement rather than mere stability, the risks still outweigh the rewards.
Ad
BASF Stock: New Analysis - 11 June
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
